References
- Kaufman D, Fairchild KD. Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants. Clin Microbiol Rev 2004;17:638–680.
- Benjamin DK Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, Duara S, Poole K, Laptook A, Goldberg R, on behalf of the National Institute of Child Health and Human Development Neonatal Research Networkl. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117:84–92.
- Manzoni P, Stolfi I, Pugni L, Decembrino L, Magnani C, Vetrano G, Tridapalli E, Corona G, Giovannozzi C, Farina D, et al A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007;356:2483–2495.
- Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, de Lucia A. Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J 1998;17:146–148.
- Sàez-Llorens X, Macias M, Maiya P, Pineros J, Jafri HS, Chatterjee A, Ruiz G, Raghavan J, Bradshaw SK, Kartsonis NA, et al Pharmacokinetics and safety of caspofungin in neonates and infants less than 3 months of age. Antimicrob Agents Chemother 2009;53:869–875.
- Odio CM, Araya R, Pinto LE, Castro CE, Vasquez S, Alfaro B. Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J 2004;23:1093–1097.
- Natarajan G, Lulic-Botica M, Rongkavilit C, Pappas A, Bedard M. Experience with caspofungin in the treatment of persistent fungemia in neonates. J Perinatol 2005;25:770–777.
- Castagnola E, Franceschi A, Natalizia AR, Mantero E, Tuo P. Combined antifungal therapy for persistent central venous catheter-related candidemia in extremely low birth weight neonates. J Chemother 2009;21:234–235.
- Madero L, Sanchez de Toledo J, Castel V, Sevilla J, Gonzalez-Esteban J, Sanz-Rodriguez C. Compassionate use study of caspofungin in children with proven or suspected invasive mycosis or persistent febrile neutropenia. J Chemother 2009;21:229–231.
- Natale F, Castronovo A, Regoli D, De Curtis M, Manzoni P. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant. Pediatr Infect Dis J 2009;28:452.
- Filippi L, Poggi C, Zozzini E, Meleleo R, Mirabile L, Fiorini P. Neonatal liver abscesses due to Candida infection effectively treated with caspofungin. Acta Pædiatr 2009;98:901–909.
- Benjamin DK Jr, Smith PB, Arrieta A, Castro L, Sànchez PJ, Kaufman D, Arnold LJ, Kovanda LL, Sawamoto T, Buell DN, et al Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clin Pharmacol Ther 2010;87:93–99.
- Queiroz-Telles F, Berezin E, Leverger G, Freire A, van der Vyver A, Chotpitayasunondh T, Konja J, Diekmann-Berndt H, Koblinger S, Groll AH, et al Micafungin Invasive Candidiasis Study Group. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J 2008;27:820–826.
- Kawaguchi C, Arai I, Yasuhara H, Sano R, Nishikubo T, Takahashi Y. Efficacy of micafungin in treating four premature infants with candidiasis. Pediatr Int 2009;51:220–224.
- Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE. Infectious Diseases Society of America guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161–189.